BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37809245)

  • 1. The Effectiveness of Common Interventions in the Management of Sickle Cell Disease in Primary Care Settings: A Review.
    Mbaezue RN; Okafor AT; Nkwocha BI; Ibeneme CN; Opara AC; Akahara DE; Okobi OE
    Cureus; 2023 Sep; 15(9):e44780. PubMed ID: 37809245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea for children with sickle cell disease in sub-Saharan Africa: A summary of the evidence, opportunities, and challenges.
    Dexter D; McGann PT
    Pharmacotherapy; 2023 May; 43(5):430-441. PubMed ID: 36906823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sickle cell disease treatment and management in India: a systematic review of interventional studies.
    Sridevi P; Sharma Y; Balakrishna SL; Babu BV
    Trans R Soc Trop Med Hyg; 2022 Dec; 116(12):1101-1111. PubMed ID: 36227060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea (hydroxycarbamide) for sickle cell disease.
    Nevitt SJ; Jones AP; Howard J
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002202. PubMed ID: 28426137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes of Primary Care Physicians Toward Sickle Cell Disease Care, Guidelines, and Comanaging Hydroxyurea With a Specialist.
    Lunyera J; Jonassaint C; Jonassaint J; Shah N
    J Prim Care Community Health; 2017 Jan; 8(1):37-40. PubMed ID: 27506442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA.
    Smeltzer MP; Howell KE; Treadwell M; Preiss L; King AA; Glassberg JA; Tanabe P; Badawy SM; DiMartino L; Gibson R; Kanter J; Klesges LM; Hankins JS;
    BMJ Open; 2021 Nov; 11(11):e050880. PubMed ID: 34789492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell anemia/sickle cell disease and pregnancy outcomes among ethnic tribes in India: an integrative mini-review.
    Ganesh B; Rajakumar T; Acharya SK; Kaur H
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4897-4904. PubMed ID: 33563075
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability.
    Ryan N; Dike L; Ojo T; Vieira D; Nnodu O; Gyamfi J; Peprah E
    BMJ Open; 2020 Nov; 10(11):e038685. PubMed ID: 33168553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
    Fortin PM; Fisher SA; Madgwick KV; Trivella M; Hopewell S; Doree C; Estcourt LJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012349. PubMed ID: 29737522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
    Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid evidence assessment of sickle cell disease educational interventions.
    Oti AE; Heyes K; Bruce F; Wilmott D
    J Clin Nurs; 2023 Mar; 32(5-6):812-824. PubMed ID: 35590440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translating sickle cell guidelines into practice for primary care providers with Project ECHO.
    Shook LM; Farrell CB; Kalinyak KA; Nelson SC; Hardesty BM; Rampersad AG; Saving KL; Whitten-Shurney WJ; Panepinto JA; Ware RE; Crosby LE
    Med Educ Online; 2016; 21():33616. PubMed ID: 27887664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Integrative Review: The Evolution of Provider Knowledge, Attitudes, Perceptions and Perceived Barriers to Caring for Patients with Sickle Cell Disease 1970-Now.
    Reich J; Cantrell MA; Smeltzer SC
    J Pediatr Hematol Oncol Nurs; 2023; 40(1):43-64. PubMed ID: 35854420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orofacial Manifestation and Dental Management of Sickle Cell Disease: A Scoping Review.
    Kakkar M; Holderle K; Sheth M; Arany S; Schiff L; Planerova A
    Anemia; 2021; 2021():5556708. PubMed ID: 34721900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Capacity of Health System and Community for Sickle Cell Disease Screening and Management Among Tribal Population in India: Protocol of an Intervention Study.
    Babu BV; Sridevi P; Surti SB; Ranjit M; Bhat D; Sarmah J; Sudhakar G; Sharma Y
    Curr Health Sci J; 2020; 46(3):270-279. PubMed ID: 33304628
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.